Your browser doesn't support javascript.
loading
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study.
Baliakas, Panagiotis; Hadzidimitriou, Anastasia; Sutton, Lesley-Ann; Minga, Eva; Agathangelidis, Andreas; Nichelatti, Michele; Tsanousa, Athina; Scarfò, Lydia; Davis, Zadie; Yan, Xiao-Jie; Shanafelt, Tait; Plevova, Karla; Sandberg, Yorick; Vojdeman, Fie Juhl; Boudjogra, Myriam; Tzenou, Tatiana; Chatzouli, Maria; Chu, Charles C; Veronese, Silvio; Gardiner, Anne; Mansouri, Larry; Smedby, Karin E; Pedersen, Lone Bredo; van Lom, Kirsten; Giudicelli, Véronique; Francova, Hana Skuhrova; Nguyen-Khac, Florence; Panagiotidis, Panagiotis; Juliusson, Gunnar; Angelis, Lefteris; Anagnostopoulos, Achilles; Lefranc, Marie-Paule; Facco, Monica; Trentin, Livio; Catherwood, Mark; Montillo, Marco; Geisler, Christian H; Langerak, Anton W; Pospisilova, Sarka; Chiorazzi, Nicholas; Oscier, David; Jelinek, Diane F; Darzentas, Nikos; Belessi, Chrysoula; Davi, Frederic; Rosenquist, Richard; Ghia, Paolo; Stamatopoulos, Kostas.
Afiliación
  • Baliakas P; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden; Hematology Department and HCT Unit, G Papanicolaou Hospital, Thessaloniki, Greece.
  • Hadzidimitriou A; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden; Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
  • Sutton LA; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Minga E; Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
  • Agathangelidis A; Università Vita-Salute San Raffaele, Milan, Italy; Division of Molecular Oncology and Department of Onco-Hematology, IRCCS, San Raffaele Scientific Institute, Milan, Italy.
  • Nichelatti M; Molecular Pathology Unit and Haematology Department, Niguarda Cancer Center, Niguarda Ca' Granda Hospital, Milan, Italy.
  • Tsanousa A; Department of Informatics, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Scarfò L; Università Vita-Salute San Raffaele, Milan, Italy; Division of Molecular Oncology and Department of Onco-Hematology, IRCCS, San Raffaele Scientific Institute, Milan, Italy.
  • Davis Z; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Yan XJ; The Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System, Manhasset, NY, USA.
  • Shanafelt T; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Plevova K; Central European Institute of Technology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
  • Sandberg Y; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Vojdeman FJ; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • Boudjogra M; Hôpital Pitié-Salpêtrière, Service d'Hématologie Biologique, Paris, France.
  • Tzenou T; First Department of Propaedeutic Medicine, University of Athens, Athens, Greece.
  • Chatzouli M; Hematology Department, Nikea General Hospital, Piraeus, Greece.
  • Chu CC; The Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System, Manhasset, NY, USA.
  • Veronese S; Molecular Pathology Unit and Haematology Department, Niguarda Cancer Center, Niguarda Ca' Granda Hospital, Milan, Italy.
  • Gardiner A; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Mansouri L; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Smedby KE; Department of Medicine, Solna, Clinical Epidemiology Unit, Karolinska Institutet, Stockholm, Sweden.
  • Pedersen LB; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • van Lom K; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Giudicelli V; IMGT-the International ImMunoGeneTics Information System, University of Montpellier, LIGM, Institut de Génétique Humaine IGH, Montpellier, France.
  • Francova HS; Central European Institute of Technology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
  • Nguyen-Khac F; Hôpital Pitié-Salpêtrière, Service d'Hématologie Biologique, Paris, France.
  • Panagiotidis P; First Department of Propaedeutic Medicine, University of Athens, Athens, Greece.
  • Juliusson G; Lund University and Hospital Department of Hematology, Lund Stem Cell Center, Lund, Sweden.
  • Angelis L; Department of Informatics, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Anagnostopoulos A; Hematology Department and HCT Unit, G Papanicolaou Hospital, Thessaloniki, Greece.
  • Lefranc MP; IMGT-the International ImMunoGeneTics Information System, University of Montpellier, LIGM, Institut de Génétique Humaine IGH, Montpellier, France.
  • Facco M; Department of Medicine, Hematology and Clinical Immunology Branch, Padua University School of Medicine, Italy; Venetian Institute of Molecular Medicine (VIMM), Padova, Italy.
  • Trentin L; Department of Medicine, Hematology and Clinical Immunology Branch, Padua University School of Medicine, Italy; Venetian Institute of Molecular Medicine (VIMM), Padova, Italy.
  • Catherwood M; Department of Haemato-Oncology, Belfast City Hospital, Belfast, UK.
  • Montillo M; Molecular Pathology Unit and Haematology Department, Niguarda Cancer Center, Niguarda Ca' Granda Hospital, Milan, Italy.
  • Geisler CH; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • Langerak AW; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Pospisilova S; Central European Institute of Technology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
  • Chiorazzi N; The Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System, Manhasset, NY, USA.
  • Oscier D; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Jelinek DF; Department of Immunology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Darzentas N; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Belessi C; Hematology Department, Nikea General Hospital, Piraeus, Greece.
  • Davi F; Hôpital Pitié-Salpêtrière, Service d'Hématologie Biologique, Paris, France.
  • Rosenquist R; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Ghia P; Università Vita-Salute San Raffaele, Milan, Italy; Division of Molecular Oncology and Department of Onco-Hematology, IRCCS, San Raffaele Scientific Institute, Milan, Italy. Electronic address: ghia.paolo@hsr.it.
  • Stamatopoulos K; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden; Hematology Department and HCT Unit, G Papanicolaou Hospital, Thessaloniki, Greece; Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
Lancet Haematol ; 1(2): e74-84, 2014 Nov.
Article en En | MEDLINE | ID: mdl-27030157
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Lancet Haematol Año: 2014 Tipo del documento: Article País de afiliación: Grecia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Lancet Haematol Año: 2014 Tipo del documento: Article País de afiliación: Grecia Pais de publicación: Reino Unido